Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-11-02, Stock:NVO, The news for the past five days is as follows:
2018-10-26: NEWS1: Investor Expectations to Drive Momentum within Paratek Pharmaceuticals, Dell Technologies, Dover, Black Hills, Kinder Morgan, and Novo Nordisk A/S — Discovering Underlying Factors of Influence.NEWS2: Novo Nordisk Reports Results From PIONEER 8, Phase 3a Trial On Type 2 Diabetes.NEWS3: Novo Nordisk Reports Results From PIONEER 8, Phase 3a Trial On Type 2 Diabetes.
2018-10-29: nan
2018-10-30: nan
2018-10-31: NEWS1: Q3 Earnings Preview For Novo Nordisk.
2018-11-01: NEWS1: Novo Nordisk (NVO) Reports In-Line Q3 Earnings, Beats Sales.NEWS2: Novo Nordisk (NVO) Reports In-Line Q3 Earnings, Beats Sales.NEWS3: Novo Nordisk (NVO) Reports In-Line Q3 Earnings, Beats Sales.NEWS4: Novo Nordisk (NVO) Q3 2018 Earnings Conference Call Transcript.NEWS5: Novo Nordisk (NVO) Q3 2018 Earnings Conference Call Transcript.NEWS6: [$$] Danish Insulin Maker Novo Nordisk Cuts Jobs, Shifts R&D Spending.NEWS7: Novo Nordisk (NVO) Q3 2018 Earnings Conference Call Transcript.NEWS8: Health Care Sector Update for 11/01/2018: TEVA, NVO, SNN, JNJ, PFE, ABT, MRK, AMGN.NEWS9: Health Care Sector Update for 11/01/2018: TEVA, NVO, SNN, JNJ, PFE, ABT, MRK, AMGN.NEWS10: Upbeat sales lift Novo Nordisk as drugmaker weathers U.S. pricing pressure.NEWS11: Upbeat sales lift Novo Nordisk as drugmaker weathers U.S. pricing pressure.NEWS12: Novo Nordisk: 3Q Earnings Snapshot.NEWS13: Novo Nordisk earnings miss expectations amid currency headwinds.NEWS14: Novo Nordisk earnings miss expectations amid currency headwinds.NEWS15: Novo Nordisk 9-month Profit Rises.NEWS16: Novo Nordisk 9-month Profit Rises.NEWS17: FDA Approves 3rd Humira Biosimilar, CLVS Tanks On Q3 Results, CRY On Watch.NEWS18: FDA Approves 3rd Humira Biosimilar, CLVS Tanks On Q3 Results, CRY On Watch.

Answer: Decrease